Department of Cellular Pathology, Southern Health and Social Care Trust, Portadown, UK.
Institute of Pathology, Belfast Trust, Belfast, UK
BMJ Case Rep. 2023 Nov 16;16(11):e258025. doi: 10.1136/bcr-2023-258025.
Atypical fibroxanthoma (AFX) is a rare low-grade sarcoma that occurs mainly in the elderly and may recur locally. There are multiple variants including keloidal AFX (KAF). KAF is characterised by a proliferation of atypical spindled and epithelioid cells admixed with bizarre pleomorphic cells. These cells intersect among broad bands of keloidal collagen. AFX is a diagnosis of exclusion so a broad panel of immunohistochemical staining should be applied to rule out other differentials (squamous cell carcinoma (SCC), melanoma, leiomyosarcoma, etc). There is added difficulty with the diagnosis of KAF as it may mimic multiple keloidal lesions, including exuberant scarring, as in this case. p53 immunohistochemistry staining can be useful in highlighting the presence of tumour cells. Additionally, next generation sequencing can detect genetic mutations identified in clonal proliferations consistent with tumour formation. KAF is easily overlooked and it should be included in the differential diagnosis for keloidal lesions showing even mild atypia.
非典型纤维黄色瘤(AFX)是一种罕见的低级别肉瘤,主要发生在老年人中,可能局部复发。有多种变体,包括瘢痕样 AFX(KAF)。KAF 的特征是存在增生的非典型梭形和上皮样细胞,混合有奇异的多形性细胞。这些细胞交错于宽阔的瘢痕样胶原带中。AFX 是一种排除性诊断,因此应应用广泛的免疫组化染色来排除其他鉴别诊断(鳞状细胞癌(SCC)、黑色素瘤、平滑肌肉瘤等)。KAF 的诊断更加困难,因为它可能模仿多种瘢痕样病变,包括本例中过度的瘢痕形成。p53 免疫组化染色可用于突出肿瘤细胞的存在。此外,下一代测序可检测到与肿瘤形成一致的克隆性增殖中存在的基因突变。KAF 很容易被忽视,对于表现出轻微非典型性的瘢痕样病变,应将其纳入鉴别诊断。